Ebola epidemic
Even if Ebola has faded from the headlines, the danger remains. As the largest and most deadly outbreak of Ebola winds down, scientists and public health officials are looking closely at what it will take to finish the job and to prepare better for the next big crisis. The apparent success of a nimble and creative clinical trial for a vaccine is a positive and instructive outcome. But many of the most important lessons come from failures in preparedness.
Here you can follow Nature’s full coverage of the crisis, including the travails of reporter Erika Check Hayden who travelled to Sierra Leone in December 2014, along with recent research and archival coverage of Ebola’s past.
Understanding the Ebola virus
From basic molecular research through to mapping and modelling. This Nature Webcast is now available to watch on demand.
Nature (17 December 2014)
WHO plans for millions of doses of Ebola vaccine by 2015
Hundreds of thousands of doses should be available to help affected countries before the end of June.
Nature (24 October 2014)
Spanish Ebola case highlights risks to health-care workers
A nurse who cared for an Ebola patient repatriated to a Madrid hospital has contracted the disease. But the news is, unfortunately, not surprising.
Nature (07 October 2014)
First US Ebola case diagnosed
Man in Dallas, Texas, is first person diagnosed outside Africa with the Zaire species of virus.
Nature (30 September 2014)
UN Security Council says Ebola is security threat
International action needed to tackle “greatest peace-time challenge the United Nations have ever faced”.
Nature (19 September 2014)
Ebola economic impacts to hit $359 million in 2014
The Ebola outbreak in West Africa is devastating the economies of Liberia, Guinea, and Sierra Leone.
Nature (17 September 2014)
